RWA Wealth Partners LLC Cuts Stock Holdings in Cigna Group $CI

RWA Wealth Partners LLC decreased its holdings in shares of Cigna Group (NYSE:CI) by 11.3% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 2,474 shares of the health services provider’s stock after selling 315 shares during the period. RWA Wealth Partners LLC’s holdings in Cigna Group were worth $818,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its holdings in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Cigna Group by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after buying an additional 98,715 shares during the period. Dodge & Cox grew its holdings in Cigna Group by 1.3% in the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock valued at $2,924,722,000 after purchasing an additional 117,125 shares during the period. GQG Partners LLC raised its position in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Valeo Financial Advisors LLC raised its holdings in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of several analyst reports. Morgan Stanley reiterated an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Wolfe Research decreased their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Zacks Research cut shares of Cigna Group from a “hold” rating to a “strong sell” rating in a report on Monday, November 3rd. Finally, Guggenheim dropped their target price on shares of Cigna Group from $350.00 to $309.00 in a research report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $339.73.

Insider Activity at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is currently owned by insiders.

Cigna Group Price Performance

Shares of CI opened at $264.54 on Monday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market cap of $70.66 billion, a P/E ratio of 14.44, a PEG ratio of 0.88 and a beta of 0.44. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a fifty day moving average price of $293.24 and a 200 day moving average price of $303.30.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. Cigna Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the business posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.